D J Livingstone1, G W Hanlon, S Dyke. 1. Sussex Pharmacy Academic Practice Unit, Southlands Hospital, Shoreham-by-Sea, West Sussex.
Abstract
AIM: To evaluate and compare the microbial contamination arising from 1 and 2 weeks' use of eye drops by hospital inpatients and hence determine the validity of apportioning a 2 week in use expiry date for these preparations. METHODS: Eye drop residues were collected from inpatients of Worthing, Southlands, and Brighton General hospitals after 7 days' use (341 samples) and also after 14 days' use (295 samples). The contents of the containers were examined for the presence of contaminating bacteria and fungi. RESULTS: The incidence of microbial contamination was shown to be not significantly different (p > 0.1 chi 2 test) between the 7 and 14 day samples. In addition, the contaminating micro-organisms were of a broadly similar pattern between the two sample groups and were mostly those normally associated with the skin. Less frequent contaminants were organisms of environmental origin. None of the micro-organisms isolated were considered to be of clinical significance and the mean number of cells found per sample was very low. CONCLUSIONS: The evidence therefore suggests that increasing the period of use for eye drops in hospitals from 7 to 14 days would not present a clinically significant threat to patients' health and yet may lead to annual savings to the NHS of Pounds 0.5 million.
AIM: To evaluate and compare the microbial contamination arising from 1 and 2 weeks' use of eye drops by hospital inpatients and hence determine the validity of apportioning a 2 week in use expiry date for these preparations. METHODS: Eye drop residues were collected from inpatients of Worthing, Southlands, and Brighton General hospitals after 7 days' use (341 samples) and also after 14 days' use (295 samples). The contents of the containers were examined for the presence of contaminating bacteria and fungi. RESULTS: The incidence of microbial contamination was shown to be not significantly different (p > 0.1 chi 2 test) between the 7 and 14 day samples. In addition, the contaminating micro-organisms were of a broadly similar pattern between the two sample groups and were mostly those normally associated with the skin. Less frequent contaminants were organisms of environmental origin. None of the micro-organisms isolated were considered to be of clinical significance and the mean number of cells found per sample was very low. CONCLUSIONS: The evidence therefore suggests that increasing the period of use for eye drops in hospitals from 7 to 14 days would not present a clinically significant threat to patients' health and yet may lead to annual savings to the NHS of Pounds 0.5 million.
Authors: Barbara Teuchner; Julia Wagner; Nikolaos E Bechrakis; Dorothea Orth-Höller; Markus Nagl Journal: Medicine (Baltimore) Date: 2015-02 Impact factor: 1.889
Authors: Tristan Daehn; Andreas Schneider; Johannes Knobloch; Olaf J C Hellwinkel; Martin Stephan Spitzer; Robert Kromer Journal: Sci Rep Date: 2021-10-13 Impact factor: 4.379